Surgalign Holdings (NASDAQ:SRGA) reported quarterly losses of $(1.22) per share which beat the analyst consensus estimate of $(1.80) by 32.22 percent. This is a 63.03 percent increase over losses of $(3.30) per share from the same period last year. The company reported quarterly sales of $20.57 million which missed the analyst consensus estimate of $20.67 million by 0.47 percent. This is a 5.76 percent decrease over sales of $21.83 million the same period last year.